Senior insider sale
Chief Scientific Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$35.0K
7.73K shares
What this filing means
WONG ALVIN F plans to sell 7.73K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $35.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/3/2024ACC: 0002006196-24-000004
Officer· Chief Scientific Officer
Since Jun 2021
7.73K
Shares to sell
$35.0K
Approx. market value
103.48K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Compensation for Services Rendered
2/10/2023
58.60KRestricted Stock Unit Grant
Compensation for Services Rendered
3/3/2022
44.88KTotal acquired103.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2023 | Restricted Stock Unit Grant Compensation for Services Rendered | 58.60K | — |
3/3/2022 | Restricted Stock Unit Grant Compensation for Services Rendered | 44.88K | — |
| Total | 103.48K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
7.73K
Market value
$35.0K
1/3/2024
Total
Units
7.73K
Value
$35.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/3/2024 | 7.73K | $35.0K | NASDAQGS | Planned |
| Total | 7.73K | $35.0K | ||